OpenURL Connection Search

Select item for more details and to access through your institution.

Uncovering the mode of action of engineered T cells in patient cancer organoids.
Published in:
Nature Biotechnology, 2023, v. 41, n. 1, p. 60, doi. 10.1038/s41587-022-01397-w
By:
- Dekkers, Johanna F.;
- Alieva, Maria;
- Cleven, Astrid;
- Keramati, Farid;
- Wezenaar, Amber K. L.;
- van Vliet, Esmée J.;
- Puschhof, Jens;
- Brazda, Peter;
- Johanna, Inez;
- Meringa, Angelo D.;
- Rebel, Heggert G.;
- Buchholz, Maj-Britt;
- Barrera Román, Mario;
- Zeeman, Amber L.;
- de Blank, Sam;
- Fasci, Domenico;
- Geurts, Maarten H.;
- Cornel, Annelisa M.;
- Driehuis, Else;
- Millen, Rosemary
Publication type:
Article
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations....
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1280826
By:
- Ammar, Delphine;
- Schapitz, Inga;
- Luu, Maik;
- Hudecek, Michael;
- Meyer, Miriam;
- Taps, Timmothy;
- Schröder, Bernd;
- Ivics, Zoltán;
- Sanges, Carmen;
- Franz, Paul;
- Koehl, Ulrike;
- Negre, Helene;
- Johanna, Inez;
- Awigena-Cook, Jacquelyn
Publication type:
Article
Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.
Published in:
Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.752699
By:
- Johanna, Inez;
- Hernández-López, Patricia;
- Heijhuurs, Sabine;
- Scheper, Wouter;
- Bongiovanni, Laura;
- de Bruin, Alain;
- Beringer, Dennis X.;
- Oostvogels, Rimke;
- Straetemans, Trudy;
- Sebestyen, Zsolt;
- Kuball, Jürgen
Publication type:
Article
TEG011 persistence averts extramedullary tumor growth without exerting off‐target toxicity against healthy tissues in a humanized HLA‐A*24:02 transgenic mice.
Published in:
Journal of Leukocyte Biology, 2020, v. 107, n. 6, p. 1069, doi. 10.1002/JLB.5MA0120-228R
By:
- Johanna, Inez;
- Hernández‐López, Patricia;
- Heijhuurs, Sabine;
- Bongiovanni, Laura;
- Bruin, Alain;
- Beringer, Dennis;
- Dooremalen, Sanne;
- Shultz, Leonard D.;
- Ishikawa, Fumihiko;
- Sebestyen, Zsolt;
- Straetemans, Trudy;
- Kuball, Jürgen
Publication type:
Article

Found: 4

Uncovering the mode of action of engineered T cells in patient cancer organoids.

Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations....

Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.

TEG011 persistence averts extramedullary tumor growth without exerting off‐target toxicity against healthy tissues in a humanized HLA‐A*24:02 transgenic mice.